A female patient reports a heart rate of 115 beats per minute that she says is not unusual—how should this tachycardia be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation and Management of Chronic Resting Tachycardia (HR 115 bpm)

A female patient with a resting heart rate of 115 bpm that she reports as "not unusual" requires systematic evaluation to distinguish inappropriate sinus tachycardia (IST) from physiological causes, followed by targeted management based on symptom burden and underlying etiology.

Initial Diagnostic Approach

The first priority is to rule out reversible causes through targeted history, physical examination, and laboratory testing 1. Specifically evaluate for:

  • Exogenous substances: caffeine, stimulants, decongestants, illicit drugs
  • Medications: bronchodilators, thyroid replacement, sympathomimetics
  • Systemic conditions: hyperthyroidism, anemia, infection, dehydration
  • Anxiety disorders (present in all elderly IST patients in one series) 2

Key Diagnostic Studies

  • 12-lead ECG (mandatory for all patients with palpitations) 3, 4: Examine P-wave morphology to distinguish IST from focal atrial tachycardia originating near the sinus node. IST shows normal sinus P-waves without sudden onset/termination, while focal AT may have abrupt changes 1.

  • Laboratory evaluation: TSH, CBC, electrolytes, toxicology screen if indicated

  • Ambulatory monitoring (24-48 hour Holter or event monitor) if diagnosis unclear 3, 4: Documents heart rate patterns throughout daily activities and correlates symptoms with rhythm

  • Echocardiography: Consider if structural heart disease suspected, particularly in elderly patients where diastolic dysfunction and LV hypertrophy may coexist 2

Management Algorithm

If Reversible Cause Identified

Treat the underlying condition (e.g., thyroid replacement adjustment, discontinue offending medications, treat anemia). This is a Class I recommendation 1.

If IST Diagnosed (Persistent Sinus Tachycardia Without Reversible Cause)

Management depends on symptom severity:

For Symptomatic Patients:

  1. First-line pharmacotherapy: Ivabradine 2.5-7.5 mg twice daily (Class IIa recommendation) 1

    • Reduces heart rate from ~98 bpm to ~85 bpm (p<0.001)
    • Improves exercise tolerance and symptoms
    • Superior to metoprolol in some studies
    • Well-tolerated; 3% experience transient visual phosphenes
    • Some patients achieve complete symptom resolution with persistent benefit even after discontinuation
  2. Alternative: Beta-blockers or calcium channel blockers (diltiazem, verapamil) 5

    • Less evidence specifically for IST
    • Reasonable option with excellent safety profile
  3. Catheter ablation: Reserved only for highly symptomatic patients refractory to medications 1

    • Critical caveat: Sinus node modification carries significant risks (phrenic nerve injury, superior vena cava syndrome, need for permanent pacemaker)
    • Risks may outweigh benefits
    • Requires extensive patient counseling about potential complications

For Asymptomatic or Minimally Symptomatic Patients:

  • Reassurance and observation may be appropriate
  • Address anxiety if present (common comorbidity) 2
  • Lifestyle modifications: reduce caffeine, ensure adequate hydration, stress management

Important Clinical Pearls

  • IST can occur across all age groups, including elderly females, and may become chronic if untreated 2. The patient stating this is "not unusual" suggests chronicity.

  • Do not confuse with focal atrial tachycardia: Focal AT has sudden onset/termination, while IST is gradual 1, 6

  • Heart rate variability indices may not reliably distinguish sympathetic vs. parasympathetic mechanisms in IST 2

  • Elderly patients with IST may develop diastolic dysfunction and LV hypertrophy over time 2, making echocardiographic surveillance reasonable

  • Avoid aggressive interventions unless symptoms significantly impair quality of life, given the modest benefit-to-risk ratio of ablation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.